An Evaluation of Human Demineralized Bone Matrices in a Rat Femoral Defect Model
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 413 (413) , 281-290
- https://doi.org/10.1097/01.blo.0000073347.50837.16
Abstract
The osteoconductive and osteoinductive potential of two human allogeneic demineralized bone matrix putties were compared in a critical-sized athymic rat femoral defect model. Defects were treated with (1) a demineralized bone matrix in a hyaluronic acid carrier, (2) a demineralized bone matrix in a glycerol carrier, (3) a hyaluronic acid carrier alone, or (4) with no implant. Radiographic examinations and histologic analyses were done at 4, 8, and 16 weeks postoperatively. Eight of the 48 defects treated with a demineralized bone matrix and none of the 36 surgical controls showed complete radiographic healing by 16 weeks and no statistically significant difference between the radiographic scores for the two demineralized bone matrix preparations was found. On histologic review, both preparations of demineralized bone matrix had passive remineralization. The largest foci of endochondral ossification were seen in limbs treated with a demineralized bone matrix in a hyaluronic acid carrier. The 8-mm rat femoral defect allows for stringent assessment of the osteoinductive potential of bone graft substitutes. Hyaluronic acid and glycerol are viable carriers for demineralized bone matrices. As both de-mineralized bone matrices tested provided an adequate osteoconductive matrix and showed some, although limited, osteoinductive capacity, these materials should be used in clinical practice only as bone graft extenders or enhancers.This publication has 25 references indexed in Scilit:
- The Cylindrical Titanium Mesh Cage for Treatment of a Long Bone Segmental Defect: Description of a New Technique and Report of Two CasesJournal of Orthopaedic Trauma, 2000
- OSTEOINDUCTIVE GROWTH FACTORS IN PRECLINICAL FRACTURE AND LONG BONE DEFECTS MODELSOrthopedic Clinics of North America, 1999
- OSTEOINDUCTIVE BONE GRAFT SUBSTITUTES FOR SPINAL FUSIONOrthopedic Clinics of North America, 1999
- The Effect of Regional Gene Therapy with Bone Morphogenetic Protein-2-Producing Bone-Marrow Cells on the Repair of Segmental Femoral Defects in Rats*Journal of Bone and Joint Surgery, 1999
- New Formulations of Demineralized Bone Matrix as a More Effective Graft Alternative in Experimental Posterolateral Lumbar Spine ArthrodesisSpine, 1999
- Osteoinduction of Human Demineralized BonePublished by Wolters Kluwer Health ,1998
- Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodentsJournal of Orthopaedic Research, 1998
- Autogenous Iliac Crest Bone Graft: Complications and Functional AssessmentClinical Orthopaedics and Related Research, 1997
- Induction of bone by a demineralized bone matrix gel: A study in a rat femoral defect modelJournal of Orthopaedic Research, 1995
- Comparison Between Allograft Plus Demineralized Bone Matrix Versus Autograft in Anterior Cervical Fusion|A Prospective Multicenter StudySpine, 1995